Drug delivery to the lungs

International Journal of Pharmaceutical Sciences Review and Research

Volumn 10, Issue 2, 2011, Pages 85-89

  Ravichandiran, V ^a   Masilamani, K ^a   Satheshkumar, S ^a   Joseprakash, D ^a  

^a VELS INSTITUTE OF SCIENCE   (India)

Author keywords

Carriers; Drug delivery devices; Lungs; Particle size; Pulmonary drug delivery

Indexed keywords

AMIKACIN; AURANTIIN; BIOMATERIAL; BUDESONIDE; CAPREOMYCIN; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; IPRATROPIUM BROMIDE; ISONIAZID; KETOTIFEN FUMARATE; MICROPARTICLE; NANOPARTICLE; POLYMER; PYRAZINAMIDE; RIFAMPICIN; SALBUTAMOL SULFATE; SUMATRIPTAN SUCCINATE; TACROLIMUS; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BIODEGRADABLE POLYMER; DOUBLE EMULSION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; HUMAN; INERT CARRIER; LIPOSOMAL DELIVERY; LUNG; METERED DOSE INHALER; MICRONIZATION; NEBULIZER; PARTICLE SIZE; POWDER INHALER; PULMONARY DRUG ADMINISTRATION; PULMONARY DRUG DELIVERY SYSTEM; RESPIRATORY FUNCTION; RESPIRATORY SYSTEM; SOLVENT EVAPORATION; SPRAY DRYING; SPRAY FREEZE DRYING; SUPERCRITICAL FLUID CRYSTALLIZATION;

EID: 83255185336     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lipinski C. Poor aqueous solubility- An industry wide problem in drug discovery. American Pharmaceutical Review, 2002, 5: 82-85.
2. Malgorzata Smola, Thierry Vandamme, and Adam Sokolowski. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and nonrespiratory diseases, International Journal of Nanomedicine, 2008, 3(1): 1-19.
3. O Callaghan, C., Nerbrink, O, Vidgren M.T. The history of inhaled drug therapy. In: Bisgaard, H., O'Callaghan, C. and Smaldone, G.C. (Ed.). Drug delivery to the lung. Marcel Dekker, New York, 2002, 1-18.
4. N. R. Labiris & M. B. Dolovich. Pulmonary drug delivery Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications, Blackwell Publishing Ltd., British Journal of Clinical Pharmacolology, 2003, 56(6): 588-599.
5. Pandey Shivanand, Shukla Paridhi, Bhatt Sweta, Choudhary Vasanti, Viral D, V. Subhash, K.K Shailesh, Manish Goyani, N. P. Jivani. Microfine Dry Powder: Pulmonary Drug Delivery System, Journal of Pharmacy Research, 2009, 2(7): 1159-1162.
6. S.P. Vyas and RP. Khar. Controlled drug delivery; concepts and advances, Vallabh Prakashan, New Delhi, 2002, 315-382.
7. O'Callaghan C. Targeting drug delivery to the lungs by inhalation, Mediators of Inflammation (Supplement), 1994. 3: S31-33
8. Pandey Shivanand et al. Local and Systemic Pulmonary Drug Delivery of Small Molecules, Journal of Pharmacy Research, 2009, 2(8): 1200-1202.
9. Mortonen, T., and Y. Yang. Deposition mechanics of pharmaceutical particles in human airways. In A. J. Hickey, editor. Inhalational Aerosols: Physical and Biological Basis for Therapy. Marcel Dekker, New York. 1996, 1-21.
10. Helena Eixarch, Eleonore Haltner-Ukomadu, Christoph Beisswenger and Udo Bock. Drug Delivery to the Lung: Permeability and Physicochemical Characteristics of Drugs as the Basis for a Pulmonary Biopharmaceutical Classification System (pBCS), Journal of Epithelial Biology & Pharmacology, 2010, 3(9): 1-14.
11. Gonda I. Systemic delivery of drugs to humans via inhalation. Journal of Aerosol Medicine, 2006, 19(1): 47-53.
12. Paul J. Atkins and Timothy M. Crowder, Paul J. Atkins and Timothy M. Crowder. The Design and Development of Inhalation Drug Delivery Systems, Modern Pharmaceutics by Marcel Dekker, 1-31.
13. Threlfall, T. Crystallization of polymorphs: Thermodynamic insight into the role of solvent, Organic Process Research & Development, 2000, 4(5): 384-390.
14. N.R. Rabbani, P.C. Seville. The influence of formulation components on the aerosolisation properties of spraydried powders, Journal of Controlled Release, 2005, 110(1): 130-140.
15. Heidi M Mansour, Yun-seok Rhee, Xiao Wu. Nanomedicine in pulmonary delivery, International Journal of Nanomedicine, 2009,4:299-319
16. Maa YF, Prestrelski SJ. Biopharmaceutical powders: Particle formation and formulation considerations, Current Pharmaceutical Biotechnology, 2000, 1(3): 283-302.
17. Rehman M, Shekunov BY, York P. Optimization of powders for pulmonary delivery using supercritical fluid technology. European Journal of Pharmaceutical Sciences, 2004, 22(1): 1-17.
18. H. H. Y. Tong and A. H. L. Chow. Control of Physical Forms of Drug Particles for Pulmonary Delivery by Spray Drying and Supercritical Fluid Processing KONA. 2006, 24: 27-40.
19. El-Baseir MM, Phipps MA, Kellaway IW. Preparation and subsequent degradation of poly(l-lactic acid) microspheres suitable for aerosolisation: a physico chemical study. International Journal of Pharmaceutics, 1997, 151(2): 145-153.
20. Newman SP. Metered dose pressurized aerosols and the ozone layer. The European Respiratory Journal, 1990, 3(10):495-497.
21. Newman SP, Clarke SW. Inhalation devices and techniques. In Asthma, 3rd edn, Clark TJH, Godfrey S, Lee TH. London: Chapman & Hall, 1992, 469-505.
22. Jones, B.E. A history of DPI capsule filling, Inhalation, 2009, 3(3): 20-23.
23. O.N.M. Mccallion et al. Jet nebulizer for pulmonary drug delivery, International Journal of Pharmaceutics, 1996, 130(1):1-11.
24. Jeffrey O.-H. Shama, Yu Zhang, Warren H. Finlay, Wilson H. Roa, Raimar Löbenberg. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung, International Journal of Pharmaceutics, 2004, 269(2): 457-467.
25. V. Kamalakkannan, A. Puratchikody, K. Masilamani, B. Senthilnathan., "Solubility enhancement of poorly soluble drugs by solid dispersion technique - A review", Journal of Pharmacy Research, 3(9)2010, 2314-2321.
26. Veronica Lassalle, Maria Lujan Ferreira, PLA Nano- and Microparticles for drug delivery: An Overview of the methods of preparation, Macromolecular Biosciences, 2007, 7(6): 767-783
27. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced Drug Delivery Reviews, 2007, 59(6):478-490
28. Schreier H, Gonzalez-Rothi RJ, Stecenko AA. Pulmonary delivery of liposomes. Journal of Controlled Release, 1993, 24(1-3): 209-223
29. Lorraine M. Nolan, Lidia Tajber, Bernard F. McDonald, Ahmad S. Barham, Owen I. Corrigan, Anne Marie Healy. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery, European Journal of Pharmaceutical Sciences, 2009, 37(5):593-602
30. Jean C. Sung, et al. Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery, Pharmaceutical Research, 2009, 26(8), 1847-1855.
31. Rajesh Pandey, Anjali Sharma, A. Zahoor, Sadhna Sharma, G.K. Khuller. Poly (DL-lactide-co-glycolide) nanoparticle based inhalable sustained drug delivery system for experimental tuberculosis, Journal of Antimicrobial chemotherapy, 2003, 52(6): 981-986.
32. Sansone R.P, Aquino P, Del Gaudio P, Colombo, P. Russo, Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying European Journal of Pharmaceutics and Biopharmaceutics,2009, 72(1): 206-213.
33. Jennifer Fiegel, Lucila Garcia-Contreras, Matthew Thomas, Jarod VerBerkmoes, Katharina Elbert, Anthony Hickey and David Edwards. Preparation and in Vivo Evaluation of a Dry Powder for Inhalation of Capreomycin, Pharmaceutical Research, 2008, 25(4): 805-811.
34. Zong-Yang Yang, Yuan Le, Ting-Ting Hu, Zhigang Shen, Jian-Feng Chen, and Jimmy Yun. Production of Ultrafine Sumatriptan Succinate Particles for Pulmonary Delivery, Pharmaceutical Research, 2008, 25(9): 2012-2018.
35. Gabrielle Pilcer, Francis Vanderbist, Karim Amighi, Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery, International Journal of Pharmaceutics, 2009, 365(1-2): 162-169
36. Handoko Adi, Paul M. Young, Hak-Kim Chan, Peter Stewart, Helen Agus, Daniela Traini. Cospray Dried Antibiotics For Dry Powder Lung Delivery, Journal Of Pharmaceutical Sciences, 2008, 97(8): 3356-3366
37. Farhan A.Alhusban and Peter C.Seville. Carbomer modified spray dried respirable powder for pulmonary delivery of salbutamol sulphate, Journal of Microencapsulation, 2009, 26(5): 444-455.
38. Malika Skiba, et al. Development of cyclodextrin microspheres for pulmonary drug delivery, Journal of Pharmacy Pharmaceutical Sciences, 2005, 8(3): 409-418.
39. Mayank Joshi, Ambikanandan Misra, DPI of liposomal ketotifen fumarate: Formulation and characterization, International Journal of Pharmaceutics, 2001, 223(1-2), 15-27.
40. Ambikanandan Misra, M.B. Chougale, B.K. Padhi, Preparation, characterization and Pharmacokinetics of nano liposomal dry powder inhaler of Tacrolimus, International Journal of Nanomedicine, 2007, 2, 1-14.
41. Yong Ho Kima and Katherine S. Shing. Supercritical fluidmicronized ipratropium bromide for pulmonary drug delivery, Powder Technology, 2008, 182(1): 25-32.
42. Yang Fanl, Wu Shan-Guang, Pan Yu-Fang, Song Feng-Lan and Li Tao Preparation and characteristics of erythromycin microspheres for lung targeting, Drug development and industrial pharmacy, 2009, 35(6): 639-645.